MindMed

MindMed

Biotechnology Research One World Trade Center 115 employees UNDER
Employees
115
Contacts
2
Emails
2
Phones
1

MindMed Overview

Headquarters
One World Trade Center
Website
mindmed.co
Industry
Biotechnology Research
Employees
115
Founded
2019
Stock Symbol
UNDER
Funding
75.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About MindMed

MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED. Social Media Guidelines: https://d1io3yog0oux5.cloudfront.net/_0e89882e36c19f988d288d9e6cd98de2/mindmed/db/2275/21511/file/MNMD+Community+Guidelines+FINAL+030325.pdf

MindMed Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

MindMed Org Chart

Sample employees and titles
Name Title Contact
Andreas Krebs Chairman, Board Director and Author
View
Nuno Gomes
View
Jessica Malberg
Email
Brenda Balenger
Email Phone

Employees by Management Level

Individual contributor 7 profiles
Director 5 profiles
Manager 3 profiles
Associate / junior 2 profiles
Executive 1 profile
VP / Head 1 profile
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 9 9 4
Healthcare 3 3 2
Executive 3 3 1
Legal 1 1 1
Operations 1 1 0

MindMed Tech Stack

Data / AI 2 profiles

Compare Similar Companies to MindMed